Elevai Labs Subsidiary Announces FDA Regulatory Pathway for EL-22

TipRanksDec 9 09:36 ET

Express News | Elevai Biosciences Announces Next Steps In Regulatory Strategy For EL-22, Prepareing For Pre-IND Meeting With FDA Anticipated In First Quarter Of 2025

BenzingaDec 9 08:14 ET

Express News | ELEVAI Labs - to File Ind Application With FDA in 2025

ReutersDec 9 08:05 ET

Express News | ELEVAI Biosciences, a Subsidiary of ELEVAI Labs Inc., Announces FDA Regulatory Pathway for El-22, a Pioneering Obesity Therapy Targeting Fat Loss and Muscle Preservation

ReutersDec 9 08:00 ET

Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry Into Hair Care Market

GlobeNewswireDec 6 07:30 ET

Express News | Elevai Labs Announces Record Sales Month For Its Elevai Skincare Division, Exceeding Previous Four Months Avg. Sales By 65%

BenzingaDec 4 08:03 ET